Roche to buy U.S. cancer drugmaker Ignyta for $1.7 billion

(Reuters) - Swiss drugmaker Roche will buy U.S. cancer drugmaker Ignyta Inc for $1.7 billion to broaden its oncology portfolio globally, the companies said on Friday.

from Reuters: Business News http://ift.tt/2CUVRFy